These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4280032)

  • 1. Mixed lymphocyte reactivity of patients with solid tumors.
    Harris J; Stewart TH
    Oncology; 1974; 30(1):33-42. PubMed ID: 4280032
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T; Takita H
    Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 4. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy.
    Ambus U; Mavlight GM; Gutterman JU; McBride CM; Hersh EM
    Int J Cancer; 1974 Sep; 14(3):291-300. PubMed ID: 4142467
    [No Abstract]   [Full Text] [Related]  

  • 6. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases].
    Zhukhina GE
    Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Evaluation of immune status in tumor patients.
    Vetto RM; Burger DR; Lilley DP
    Arch Surg; 1974 Apr; 108(4):558-60. PubMed ID: 4131415
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count.
    Brugarolas A; Han T; Takita H; Minowada J
    N Y State J Med; 1973 Mar; 73(6):747-50. PubMed ID: 4510958
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro methods of assessing lymphocyte transformation in patients undergoing radiotherapy for bronchogenic cancer.
    Jenkins VK; Olson MH; Ellis HN
    Tex Rep Biol Med; 1973; 31(1):19-28. PubMed ID: 4708575
    [No Abstract]   [Full Text] [Related]  

  • 10. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
    Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
    Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal lymphocyte protein synthesis in bronchogenic carcinoma.
    Whitcomb ME; Parker RL
    Cancer; 1977 Dec; 40(6):3014-8. PubMed ID: 303935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma.
    Eck HP; Drings P; Dröge W
    J Cancer Res Clin Oncol; 1989; 115(6):571-4. PubMed ID: 2558118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro lymphocyte blastogenesis: a prognostic test in patients with neoplastic disease.
    Han T
    J Surg Oncol; 1973 Jun; 5(6):567-74. PubMed ID: 4129688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological monitoring of patients operated on for epidermoid bronchogenic carcinoma].
    Dominioni L; Dionigi R; Cremaschi P; Nascimbene C; Cividini F; Mori A; Pecis C; Asti S; Moncalvo F; Campani M
    Chir Ital; 1981 Feb; 33(1):47-59. PubMed ID: 7261218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subsets in bronchoalveolar lavage fluid and in circulating blood in epidermoid bronchogenic carcinoma.
    Piazza G; Marchi E; Scaglione F; Montoli CC; Losi S; Scarpazza G
    Respiration; 1990; 57(1):28-36. PubMed ID: 2359893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of pre-treatment lymphocyte count and T cell levels in localized bronchogenic carcinoma.
    Dellon AL; Potvin C; Chretien PB
    J Surg Oncol; 1979; 12(3):253-61. PubMed ID: 228122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
    García MS; Barañao RI; Fernández O; Rumi LS
    Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
    Alsabti EA
    Oncology; 1979; 36(4):171-5. PubMed ID: 157453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anticancer therapy of lymphocyte cytotoxicity in lung cancer patients.
    Manabe H; Yasumoto K; Ohta M; Toyohira K; Nomoto K
    Gan; 1977 Aug; 68(4):477-82. PubMed ID: 357239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.